4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005235
CHIEF COMMERCIAL OFFICER gave up 1,710 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 1,844 shares (grant or award)
- CHIEF COMMERCIAL OFFICER acquired 3,131 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-01-15 | Grant or award | +1,844 | $9.56 | $17,629 | 10,008 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-03-16 | Option exercise | +994 | 11,002 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-03-16 | Shares withheld for taxes | −543 | $11.46 | $6,223 | 10,459 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-03-20 | Option exercise | +2,137 | 12,596 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-03-20 | Shares withheld for taxes | −1,167 | $11.12 | $12,977 | 11,429 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-03-16 | Option exercise · Restricted Share Unit | −994 | 1,988 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-03-20 | Option exercise · Restricted Share Unit | −2,137 | 0 | D | ||
Loading xslF345X04/form4-03202023_090303.xml…